Recently, lactoferrin has been suggested as a neuroprotective agent because the intranasal delivery of lactoferrin into AD mice can augment α-secretase-dependent APP processing through the ERK1/2-CREB and HIF-1α pathways [163]. The gene discussed is APP; the disease is Alzheimer disease.